Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice. (Q45354666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

title

Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

Valentina Gatta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

author name string

E Reisoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

E Gambini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

I Appolloni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

M Barilari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

L Menotti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

P Malatesta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

publication date

21 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

788-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996742 AND SRC:MED&resulttype=core&format=json

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

13 February 2020

cites work

1 reference

Herpes simplex virus oncolytic therapy for pediatric malignancies

21 January 2018

1 reference

Rethinking herpes simplex virus: the way to oncolytic agents

21 January 2018

1 reference

The molecular basis of herpesviruses as oncolytic agents

21 January 2018

1 reference

Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver

21 January 2018

1 reference

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

21 January 2018

1 reference

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

21 January 2018

1 reference

OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma

21 January 2018

1 reference

Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma

21 January 2018

1 reference

Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.

21 January 2018

1 reference

Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells

21 January 2018

1 reference

Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas

21 January 2018

1 reference

Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs).

21 January 2018

1 reference

Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma

21 January 2018

1 reference

Genetics of natural resistance to herpesvirus infections in mice

21 January 2018

1 reference

PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors.

21 January 2018

1 reference

Six3 controls the neural progenitor status in the murine CNS

21 January 2018

1 reference

Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma

21 January 2018

1 reference

PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2

21 January 2018

1 reference

A potential role for CXCR3 chemokines in the response to ocular HSV infection

21 January 2018

1 reference

Re-evaluating natural resistance to herpes simplex virus type 1.

21 January 2018

1 reference

Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci

21 January 2018

1 reference

Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.

21 January 2018

1 reference

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

21 January 2018

1 reference

21 January 2018

Oncolytic virotherapy

1 reference

New insights on adenovirus as vaccine vectors

21 January 2018

1 reference

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model

21 January 2018

1 reference

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

21 January 2018

1 reference

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

21 January 2018

1 reference

Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression.

21 January 2018

1 reference

Efficacy and safety/toxicity study of recombinant vaccinia virus JX-863 in two immunocompetent animal models of glioma.

21 January 2018

1 reference

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin

21 January 2018

1 reference

Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses.

21 January 2018

1 reference

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

Role of p53 in HER2-induced proliferation or apoptosis

21 January 2018

1 reference

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

7 January 2021

Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma

1 reference

7 January 2021

Gene therapy and targeted toxins for glioma

1 reference

7 January 2021